Dur brzuszny
Diagnostyka i diagnoza

Diagnostyka duru brzusznego (typhus) wymaga kompleksowego podejścia łączącego ocenę kliniczną, wywiad epidemiologiczny oraz badania laboratoryjne. Kluczową rolę odgrywają testy serologiczne, zwłaszcza pośredni test immunofluorescencyjny (IFA), który jest złotym standardem i wymaga wykazania czterokrotnego wzrostu miana przeciwciał między próbkami pobranymi w odstępie 2-3 tygodni. Testy ELISA wykrywają przeciwciała IgM i IgG z czułością i swoistością powyżej 90%, natomiast test Weila-Felixa cechuje niska czułość (do 50%). Metody molekularne, takie jak PCR, umożliwiają wykrycie materiału genetycznego bakterii we wczesnej fazie choroby, przed pojawieniem się przeciwciał, z wysoką swoistością i zmienną czułością zależną od czasu pobrania próbki i fazy choroby. Diagnostyka immunohistochemiczna (IHC) pozwala na wykrycie antygenów Rickettsia w tkankach, szczególnie w wycinkach skóry z escharu. Wartości odcięcia w testach serologicznych powinny być lokalnie walidowane, a pojedynczy wynik serologiczny ma ograniczoną wartość diagnostyczną ze względu na utrzymywanie się przeciwciał po przebytej infekcji.

Diagnostyka duru brzusznego

Diagnoza duru brzusznego (typhus) stanowi istotne wyzwanie kliniczne, zwłaszcza w początkowej fazie choroby, gdy objawy mogą być niespecyficzne i przypominać inne choroby gorączkowe. Właściwa diagnoza zależy od kombinacji oceny klinicznej pacjenta, wywiadu epidemiologicznego oraz badań laboratoryjnych12. Diagnostyka laboratoryjna jest kluczowa dla potwierdzenia zakażenia, szczególnie gdy klasyczny obraz kliniczny jest niekompletny3.

Metody serologiczne

Badania serologiczne są podstawową metodą diagnostyczną w durze brzusznym. Pośród dostępnych testów najbardziej powszechne są14:

  • Pośredni test immunofluorescencyjny (IFA) – uznawany za złoty standard diagnostyczny, wykrywa przeciwciała skierowane przeciwko riketsji
  • Test ELISA (enzyme-linked immunosorbent assay) – wykrywa przeciwciała IgM i IgG
  • Testy immunochromatograficzne (ICT) – szybkie testy diagnostyczne
  • Test Weila-Felixa – historyczny test, obecnie rzadziej używany ze względu na niską czułość i swoistość

56

Najważniejszym badaniem serologicznym jest test immunofluorescencji pośredniej (IFA), pozwalający na wykrycie wzrostu miana przeciwciał w surowicy. Dla potwierdzenia rozpoznania konieczne jest wykazanie czterokrotnego wzrostu miana przeciwciał między próbkami pobranymi w odstępie co najmniej 2-3 tygodni (próbka ostra i w fazie zdrowienia)37.

Warto podkreślić, że pojedynczy wynik badania serologicznego ma ograniczoną wartość diagnostyczną, ponieważ przeciwciała mogą utrzymywać się przez długi czas po przebytej infekcji. Ponadto, przeciwciała zwykle nie są wykrywalne wcześniej niż po 7 dniach od wystąpienia objawów89.

Diagnostyka molekularna

Metody molekularne, szczególnie reakcja łańcuchowa polimerazy (PCR), stanowią coraz ważniejszą opcję diagnostyczną w durze brzusznym. PCR umożliwia wykrycie materiału genetycznego bakterii w próbkach krwi, osocza lub wycinku skóry103. Główne zalety diagnostyki molekularnej obejmują:

  • Możliwość wykrycia infekcji we wczesnej fazie choroby, zanim pojawią się przeciwciała
  • Wysoka swoistość – możliwość rozróżnienia między gatunkami Rickettsia
  • Szybszy wynik w porównaniu do metod serologicznych

1112

PCR wykazuje najwyższą czułość, gdy próbki pobierane są w pierwszym tygodniu choroby, przed rozpoczęciem antybiotykoterapii11. Warto jednak pamiętać, że czułość PCR może być różna w zależności od typu próbki, czasu jej pobrania i nasilenia choroby3.

Immunohistochemia

Metody immunohistochemiczne (IHC) mogą być stosowane do wykrywania antygenów Rickettsia w tkankach. Badanie to jest wykonywane na wycinkach skóry, zazwyczaj pobranych z charakterystycznej zmiany skórnej – escharu (strupu), jeśli występuje1314. IHC może wykryć zakażenie grupą riketsji duru (w tym R. prowazekii i R. typhi) w utrwalonych formalinowo próbkach tkanek13.

Podejście do diagnostyki duru brzusznego

Właściwe podejście diagnostyczne do duru brzusznego powinno uwzględniać szereg elementów, w tym wywiad epidemiologiczny, objawy kliniczne oraz wyniki badań laboratoryjnych15.

Ocena kliniczna

Rozpoznanie duru brzusznego należy podejrzewać u pacjentów z charakterystycznym zespołem objawów, do których należą716:

  • Nagła gorączka
  • Silny ból głowy
  • Bóle mięśniowe
  • Wysypka (zwykle plamisto-grudkowa)
  • Wylewy podspojówkowe (w niektórych przypadkach)
  • Zaburzenia świadomości

15

Szczególnie ważny jest wywiad dotyczący podróży do rejonów endemicznych, kontaktu z wektorami (wszy, pchły) lub ekspozycji na ich żywicieli1711. W przypadku duru endemicznego (pchlego) istotny jest wywiad dotyczący kontaktu z gryzoniami, a w przypadku duru epidemicznego (wszawego) – informacje o warunkach higienicznych i sanitarnych7.

Algorytm diagnostyczny

Optymalny algorytm diagnostyczny w durze brzusznym obejmuje169:

  1. Ocenę kliniczną i wywiad epidemiologiczny
  2. Podstawowe badania laboratoryjne (morfologia, biochemia)
  3. Pobranie próbki surowicy w fazie ostrej
  4. Rozpoczęcie empirycznej antybiotykoterapii przy silnym podejrzeniu klinicznym
  5. Wykonanie badań serologicznych (IFA lub ELISA) i/lub molekularnych (PCR)
  6. Pobranie próbki surowicy w fazie zdrowienia (2-4 tygodnie później)
  7. Porównanie miana przeciwciał w próbkach z fazy ostrej i zdrowienia

12

Warto podkreślić, że leczenie nie powinno być opóźniane w oczekiwaniu na wyniki badań diagnostycznych, jeśli istnieje uzasadnione podejrzenie duru brzusznego912.

Trudności diagnostyczne

Diagnostyka duru brzusznego napotyka na szereg wyzwań18:

  • Objawy początkowe mogą przypominać inne choroby gorączkowe, takie jak denga, malaria czy bruceloza
  • Przeciwciała nie są wykrywalne w początkowej fazie choroby
  • Reakcje krzyżowe w testach serologicznych między różnymi gatunkami Rickettsia
  • Ograniczona dostępność specjalistycznych testów diagnostycznych w niektórych regionach
  • Wcześniejsze leczenie antybiotykami może wpływać na wyniki badań

1718

W regionach, gdzie dur brzuszny występuje endemicznie, często stosuje się podejście empiryczne, rozpoczynając leczenie antybiotykami przy podejrzeniu klinicznym, jeszcze przed uzyskaniem wyników badań diagnostycznych19.

Rodzaje duru i ich specyfika diagnostyczna

Istnieją różne formy duru, z których każda ma pewne specyficzne cechy diagnostyczne4.

Dur endemiczny (pchli)

Dur endemiczny (pchli), wywoływany przez Rickettsia typhi, jest najczęstszą formą duru w krajach rozwiniętych8. Specyfika diagnostyczna obejmuje20:

  • Łagodniejszy przebieg niż dur epidemiczny
  • Badanie serologiczne z użyciem antygenów specyficznych dla R. typhi
  • PCR może rozróżnić infekcję R. typhi od innych riketsji
  • W diagnostyce różnicowej należy uwzględnić inne rikettsjozy przenoszone przez pchły

821

Wiele laboratoriów komercyjnych oferuje testy serologiczne wykrywające przeciwciała przeciwko R. typhi, ale ważne jest, aby pamiętać, że testy ELISA lub EIA nie są wiarygodne w diagnostyce chorób rikettsyjnych8.

Dur epidemiczny (wszawy)

Dur epidemiczny (wszawy), wywoływany przez Rickettsia prowazekii, jest obecnie rzadki, ale historycznie odpowiadał za liczne epidemie22. Specyficzne cechy diagnostyczne obejmują7:

  • Cięższy przebieg kliniczny niż dur endemiczny
  • Wywiad wskazujący na narażenie na wszy lub przebywanie w warunkach zatłoczenia
  • Badania serologiczne z użyciem antygenów specyficznych dla R. prowazekii
  • Możliwość nawrotu choroby po latach (choroba Brilla-Zinssera)

1023

Choroba Brilla-Zinssera (nawrotowy dur epidemiczny) może być potwierdzona u pacjenta z historią pierwotnego duru epidemicznego, u którego występują nawracające objawy i wzrost miana przeciwciał IgG, co wskazuje na wtórną odpowiedź immunologiczną10.

Dur krzaczasty (tsutsugamushi)

Dur krzaczasty (scrub typhus), wywoływany przez Orientia tsutsugamushi, występuje głównie w regionie Azji i Pacyfiku24. Specyficzne cechy diagnostyczne obejmują2425:

  • Charakterystyczny strup (eschar) w miejscu ukłucia przez roztocze
  • Znaczna zmienność antygenowa wymaga testów serologicznych z lokalnymi szczepami
  • Test PCR z krwi lub biopsji skóry (z escharu) jest szczególnie przydatny
  • Test Weila-Felixa z antygenem OX-K ma niską czułość, ale jest tani i łatwy do wykonania

2627

W przypadku duru krzaczastego diagnostyka laboratoryjna jest szczególnie ważna, gdy nie występuje charakterystyczny eschar, co zdarza się u części pacjentów27.

Interpretacja wyników diagnostycznych

Prawidłowa interpretacja wyników badań diagnostycznych w durze brzusznym wymaga zrozumienia ich ograniczeń i wartości diagnostycznej26.

Wartości odcięcia w testach serologicznych

Wartości odcięcia (cut-off) w testach serologicznych mogą być różne w zależności od regionu geograficznego i populacji26. Dla IFA stosowane są różne wartości odcięcia, od 1:10 do 1:400, często bez odpowiedniego ustalenia poziomów przeciwciał w zdrowej populacji lokalnej26. Wartości odcięcia powinny być walidowane lokalnie, aby odróżnić tło immunologiczne od ostrej infekcji28.

Potwierdzenie laboratoryjne duru wymaga wykazania czterokrotnego wzrostu miana przeciwciał między dwiema próbkami pobranymi w odstępie co najmniej 2-3 tygodni37. Pojedynczy wynik pozytywny w połączeniu z odpowiednimi objawami klinicznymi i laboratoryjnymi może być podstawą do postawienia prawdopodobnego rozpoznania9.

Czułość i swoistość testów

Czułość i swoistość testów diagnostycznych w durze brzusznym różnią się znacząco24:

  • Test Weila-Felixa: niska czułość (do 50%) i swoistość
  • IFA: czułość 70-100%, swoistość 60-100% (zależnie od wartości odcięcia)
  • ELISA: czułość i swoistość >90% przy odpowiedniej wartości odcięcia
  • PCR: wysoka swoistość, czułość zależna od fazy choroby i typu próbki
  • Szybkie testy immunochromatograficzne: zróżnicowana czułość i swoistość

2930

W badaniach porównujących różne metody diagnostyczne w durze krzaczastym, czułość i swoistość ELISA wykrywającego przeciwciała IgM osiągała 84% i 94,8%, co czyni go dobrą alternatywą dla IFA30. Z kolei szybkie testy immunochromatograficzne miały zróżnicowaną czułość (66%, 95% CI: 0,37-0,86) i swoistość (92%, 95% CI: 0,83-0,97)31.

Ograniczenia testów diagnostycznych

Każda z metod diagnostycznych ma swoje ograniczenia28:

  • IFA wymaga specjalistycznego sprzętu, jest kosztowna i wymaga doświadczenia
  • Testy serologiczne nie są przydatne we wczesnej fazie choroby (przed 7-10 dniem)
  • PCR ma najwyższą czułość w pierwszym tygodniu choroby, przed antybiotykoterapią
  • Izolacja patogenu w hodowli komórkowej wymaga specjalistycznych warunków i jest czasochłonna
  • Testy immunochromatograficzne mają zmienną czułość i swoistość

2832

Istotne jest również, że przeciwciała mogą utrzymywać się przez lata po przebytej infekcji, co może prowadzić do fałszywie dodatnich wyników, szczególnie w regionach endemicznych7. Dlatego tylko wykazanie zmian w mianie przeciwciał między parą próbek może być uznane za wiarygodne potwierdzenie ostrej infekcji32.

Badania uzupełniające

Oprócz specyficznych badań diagnostycznych, w ocenie pacjenta z podejrzeniem duru brzusznego pomocne są badania uzupełniające1.

Badania laboratoryjne

Badania laboratoryjne mogą pomóc w ocenie stopnia ciężkości choroby i wykluczeniu innych jednostek w diagnostyce różnicowej1. Typowe zmiany w badaniach laboratoryjnych obejmują33:

  • Wczesna limfopenia z późną limfocytozą
  • Małopłytkowość
  • Podwyższone poziomy enzymów wątrobowych (75-95% przypadków)
  • Hipoalbuminemia (około 50% przypadków)
  • Hiperbilirubinemia (rzadko)

339

W ciężkich przypadkach mogą wystąpić zaburzenia elektrolitowe, podwyższone markery stanu zapalnego oraz zaburzenia funkcji nerek9.

Badania obrazowe

Badania obrazowe nie są specyficznie wskazane w diagnostyce duru brzusznego10. Mogą być jednak przydatne w ocenie powikłań lub w przypadku podejrzenia zajęcia narządów wewnętrznych10. W niektórych przypadkach duru krzaczastego zdjęcie rentgenowskie klatki piersiowej może ujawnić zmiany zapalne w płucach34.

Nowe metody diagnostyczne

W ostatnich latach obserwuje się rozwój nowych metod diagnostycznych w durze brzusznym, które mogą przyczynić się do poprawy diagnostyki tej choroby35.

Testy point-of-care

Szybkie testy diagnostyczne typu point-of-care (POCT) są szczególnie przydatne w obszarach o ograniczonych zasobach i w warunkach ambulatoryjnych31. Obejmują one przede wszystkim testy immunochromatograficzne, które pozwalają na szybką diagnostykę przy łóżku pacjenta5.

Nowsze testy POCT, takie jak ImmuneMed Scrub Typhus Rapid, wykazują wysoką czułość (98,6%) i swoistość (97,6%) w porównaniu do starszych wersji testów3637. Istnieje jednak potrzeba standaryzacji metod i raportowania dokładności diagnostycznej w celu zmniejszenia heterogeniczności między badaniami i zwiększenia porównywalności wyników38.

Nowe technologie sekwencjonowania

Technologie sekwencjonowania nowej generacji (NGS) są obiecującym narzędziem diagnostycznym w durze brzusznym39. NGS może identyfikować patogeny w sposób dokładny i szybki, nawet przy braku charakterystycznych objawów klinicznych40.

W opisanym przypadku duru krzaczastego, NGS pozwoliło na zidentyfikowanie Orientia tsutsugamushi jako patogenu wywołującego chorobę, gdy inne metody diagnostyczne zawiodły40. NGS może być szczególnie przydatne w diagnostyce ciężkich przypadków duru z niewydolnością wielonarządową lub wstrząsem septycznym40.

Testy antygenowe

Testy wykrywające antygeny patogenów są obiecującą alternatywą dla testów serologicznych, szczególnie we wczesnej fazie choroby5. Test antygenowy w formacie immunochromatograficznym (ICT AgTK) wykrywający białko GroEL O. tsutsugamushi w próbkach surowicy wykazał 85% czułość diagnostyczną, 100% swoistość i 92,5% dokładność w porównaniu z diagnozą kliniczną i standardowym IFA41.

Testy antygenowe mają potencjał do stosowania w diagnostyce wczesnej fazy duru, szczególnie w ośrodkach o ograniczonych zasobach, dzięki łatwości wykonania i szybkiemu czasowi uzyskania wyniku41.

Podsumowanie diagnostyki duru brzusznego

Diagnostyka duru brzusznego opiera się na kombinacji oceny klinicznej, wywiadu epidemiologicznego oraz badań laboratoryjnych16. Badania serologiczne, szczególnie IFA, pozostają standardem diagnostycznym, ale mają ograniczenia, zwłaszcza we wczesnej fazie choroby24.

Metody molekularne, takie jak PCR, są coraz szerzej stosowane i mogą być szczególnie przydatne we wczesnej fazie choroby, przed pojawieniem się przeciwciał11. Rozwój nowych technologii diagnostycznych, takich jak testy point-of-care, sekwencjonowanie nowej generacji i testy antygenowe, może przyczynić się do poprawy diagnostyki duru brzusznego540.

Ze względu na potencjalnie ciężki przebieg duru brzusznego i skuteczność wczesnej antybiotykoterapii, leczenie powinno być rozpoczęte przy uzasadnionym podejrzeniu klinicznym, jeszcze przed uzyskaniem wyników badań diagnostycznych912. Ostateczne potwierdzenie diagnozy często uzyskuje się retrospektywnie, na podstawie badań serologicznych3.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Typhus Workup: Laboratory Studies, Imaging Studies, Histologic Findings
    https://emedicine.medscape.com/article/231374-workup
    Laboratory studies are not particularly helpful in confirming a diagnosis of flea-borne rickettsioses. These studies assist the clinician in assessing the degree of severity of the illness and in helping exclude other diseases in the differential diagnoses. […] The diagnosis of flea-borne Rickettsioses is clinically suggested when the appropriate historical elements are elicited from a patient who presents with the characteristic symptoms and signs. […] Diagnosis may be confirmed using laboratory tests; however, more than 1 week may pass before patients mount a demonstrable immune response that can be measured serologically. […] Laboratory confirmation of Rickettsioses is obtained irrespective of the clinical presentation. […] Indirect immunofluorescence assay (IFA) is the test of choice, and is used to evaluate for a rise in the antibody titer, which indicates an acute primary disease. Both acute and convalescent serum should be obtained for diagnosis.
  • #2 Clinical Overview of Epidemic Typhus | Typhus Fevers | CDC
    https://www.cdc.gov/typhus/hcp/clinical-overview/clinical-overview-of-epidemic-typhus.html
    Symptoms include fever, headache, rash, and altered mental status. Laboratory confirmation is typically based on serological tests detecting IgG or IgM antibodies. […] Diagnosis is based on clinical findings and epidemiologic factors, as diagnostic tests are not reliable early in the illness course. Epidemic typhus should be considered in patients with persistent fever, a history of body louse exposure in congregate or other crowded settings, or persons who may have come in contact with flying squirrels or their nests. […] R. prowazekii can be detected via indirect fluorescent antibody (IFA) test, immunohistochemistry (IHC), polymerase chain reaction (PCR) assay of blood, plasma, or tissue samples, or culture isolation. Serologic tests are the most common means of confirmation and can be used to detect either IgG or IgM antibodies.
  • #3 Clinical Overview of Murine Typhus | Typhus Fevers | CDC
    https://www.cdc.gov/typhus/hcp/clinical-overview/clinical-overview-of-murine-typhus.html
    Laboratory confirmation primarily relies on serological tests demonstrating a four-fold rise in antibody titer between acute and convalescent samples. […] Diagnosis is serologically confirmed by demonstrating a four-fold rise in antibody titer between acute and convalescent samples. […] PCR can detect R. typhi during acute illness, and is most sensitive when performed on specimens collected during the first week of illness, and prior to the start of doxycycline. […] However, PCR is insufficiently sensitive to rule out infection, and a negative PCR result should not dissuade clinicians from treating patients in whom murine typhus is suspected. […] Only demonstration of recent changes in titers between paired specimens are considered to be a reliable retrospective serologic confirmation of acute murine typhus infection.
  • #4 Typhus – Wikipedia
    https://en.wikipedia.org/wiki/Typhus
    The main method of diagnosing typhus of all types is laboratory testing. It is most commonly done with an indirect immunofluorescence antibody IFA test for all types of typhus. This tests a sample for the antibodies associated with typhus. It can also be done with either immunohistochemistry (IHC) or polymerase chain reaction (PCR) tests excluding scrub typhus. Scrub typhus is not tested with IHC or PCR but is instead tested with the IFA test as well as indirect immunuoperoxidase (IIP) assays. […] Without treatment, death may occur in 10% to 60% of people with epidemic typhus, with people over age 50 having the highest risk of death. In the antibiotic era, death is uncommon if doxycycline is given. In one study of 60 people hospitalized with epidemic typhus, no one died when given doxycycline or chloramphenicol.
  • #5 GroEL Chaperonin-Based Assay for Early Diagnosis of Scrub Typhus
    https://www.mdpi.com/2075-4418/12/1/136
    A point-of-care diagnostic for early and rapid diagnosis of scrub typhus caused by Orientia tsutsugamushi is required for prompt and proper treatment of patients presenting with undifferentiated febrile illnesses. […] In-house validation revealed that the ICT AgTK gave 85, 100 and 95% diagnostic sensitivity, specificity and accuracy, respectively, compared to the combined clinical features and standard IFA when tested on 40 frozen serum samples. […] The ICT AgTK is easy to perform with rapid turn-around time. It has the potential to be used as an important tool for on-site and early scrub typhus diagnosis by allowing testing of freshly collected samples (serum, plasma or buffy coat), especially in resource-limited healthcare settings. […] In this study, we offer an antigen detection test kit (AgTK) in an immunochromatographic (ICT; lateral flow) format for rapid, early and on-site diagnosis of scrub typhus.
  • #6 Diagnostic evaluation of IgM ELISA and IgM Immunofluorescence assay for the diagnosis of Acute Scrub Typhus in central Nepal | BMC Infectious Diseases | Full Text
    https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-4861-y
    Scrub typhus is an acute febrile illness caused by the obligate intracellular bacterium, Orientia tsutsugamushi. Immunochromatography (ICT) and IgM ELISA are two of the routinely employed antibody based assays for diagnosis of Scrub typhus fever in Nepal, although the recommended gold standard diagnostic test is IgM Immunofluorescence assay (IFA). This study evaluated InBios Scrub Typhus Detect Immunoglobulin M (IgM) ELISA and IgM Immunofluorescence assays in single serum sample at the time of admission. […] Although IgM IFA is considered the gold standard test for the diagnosis of scrub typhus cases, it is relatively expensive, requires trained personal and a microscope with fluorescence filters. Scrub typhus IgM ELISA may be the best alternative test and possible viable option for resource limited endemic countries like Nepal.
  • #7 Clinical Overview of Epidemic Typhus | Typhus Fevers | CDC
    https://www.cdc.gov/typhus/hcp/clinical-overview/clinical-overview-of-epidemic-typhus.html
    Diagnosis is typically confirmed by documenting a four-fold rise in antibody titer between acute and convalescent samples. […] Because IgG antibody titers may persist in some individuals for years after the original exposure, only demonstration of recent changes in titers between paired specimens can be considered reliable serological confirmation of an acute epidemic typhus infection. […] Doxycycline is the treatment of choice for suspected cases of acute epidemic typhus and Brill-Zinsser disease in adults and children of all ages.
  • #7 Clinical Overview of Epidemic Typhus | Typhus Fevers | CDC
    https://www.cdc.gov/typhus/hcp/clinical-overview/clinical-overview-of-epidemic-typhus.html
    Symptoms include fever, headache, rash, and altered mental status. Laboratory confirmation is typically based on serological tests detecting IgG or IgM antibodies. […] Diagnosis is based on clinical findings and epidemiologic factors, as diagnostic tests are not reliable early in the illness course. Epidemic typhus should be considered in patients with persistent fever, a history of body louse exposure in congregate or other crowded settings, or persons who may have come in contact with flying squirrels or their nests. […] R. prowazekii can be detected via indirect fluorescent antibody (IFA) test, immunohistochemistry (IHC), polymerase chain reaction (PCR) assay of blood, plasma, or tissue samples, or culture isolation. Serologic tests are the most common means of confirmation and can be used to detect either IgG or IgM antibodies.
  • #8 Flea-borne Typhus | Texas DSHS
    https://www.dshs.texas.gov/notifiable-conditions/zoonosis-control/zoonosis-control-diseases-and-conditions/flea-borne-typhus
    Many commercial laboratories offer rickettsial serology testing, but it should be noted that ELISA or EIA tests are not reliable for rickettsial disease diagnosis. Also, antibodies are typically not detectable until about 7 days after illness onset, so a negative test result on a sample taken prior to a week after illness onset does not rule out rickettsial infection (repeat testing after this time is critical to confirm or rule out infection). Molecular testing is a more definitive testing option for acute infection. Whole blood collected within a few days of illness onset may be tested by PCR in an attempt to detect Rickettsia spp. Samples may be sent to DSHS for Rickettsia Real-Time PCR.
  • #8 Flea-borne Typhus | Texas DSHS
    https://www.dshs.texas.gov/notifiable-conditions/zoonosis-control/zoonosis-control-diseases-and-conditions/flea-borne-typhus
    Flea-borne (also known as murine or endemic) typhus is a rickettsial disease caused by Rickettsia typhi. Infected fleas carried by rats, opossums, cats, dogs, and other small mammals can spread these bacteria. The disease is like louse-borne typhus (R. prowazekii) but is generally milder. Disease onset is often sudden, and symptoms may include fever, headache, chills, weakness, nausea/vomiting, body aches, and rash. Flea-borne typhus can be a serious disease and can result in hospitalization. This is more likely with delayed diagnosis and treatment. […] A doctor can conduct tests to tell you if you have flea-borne typhus. […] Laboratory testing is required to confirm a diagnosis of flea-borne typhus. The most efficient and readily available diagnostic method to confirm infection with R. typhi is the detection of IgG antibodies to R. typhi using an indirect fluorescent antibody (IFA) test in acute and convalescent serum specimens collected at least 3 weeks apart. However, because antibodies for rickettsial diseases can be cross-reactive, specimens should be tested against a panel of Rickettsia antigens, including, at a minimum, R. rickettsii and R. typhi, to differentiate between the spotted fever group and non-spotted fever group Rickettsia spp.
  • #9 Department of Public Health – Acute Communicable Disease Control
    http://www.publichealth.lacounty.gov/acd/TyphusTesting.htm
    Providers should consider a diagnosis of flea-borne typhus in patients with a non-specific febrile illness with headache, myalgia, rash and laboratory abnormalities including leukopenia, thrombocytopenia and elevation of hepatic transaminases, without alternate identifiable etiology. […] As symptoms are non-specific and laboratory testing is unreliable in acute phases of infection, treatment decisions should be based on clinical presentation and exposure history. […] Treatment for patients with suspected flea-borne typhus should not be delayed pending diagnostic tests. […] Laboratory diagnosis can be conducted through serologic testing for R.typhi IgG and IgM antibodies. […] Confirmation of R. typhi infection requires paired serology of acute and convalescent samples (drawn 2 weeks later) demonstrating a four-fold increase in IgG titers.
  • #9 Department of Public Health – Acute Communicable Disease Control
    http://www.publichealth.lacounty.gov/acd/TyphusTesting.htm
    However, as not all patients return for additional testing, a probable diagnosis can be made with a single positive sample plus supportive clinical and laboratory criteria. […] Serological tests for both R. typhi and R. rickettsia are available at most commercial laboratories. […] The LAC DPH Public Health Laboratory (PHL) provides both serological and PCR testing for Rickettsia. […] R. typhi and R. rickettsii serum testing is available and PCR whole blood testing can detect all Rickettsia species. […] Flea-borne typhus and other rickettsial infections are reportable in California.
  • #10 Typhus Workup: Laboratory Studies, Imaging Studies, Histologic Findings
    https://emedicine.medscape.com/article/231374-workup
    Brill-Zinsser disease can be confirmed in a patient with a history of primary epidemic typhus who has recurrent symptoms and signs of typhus and a rise in the immunoglobulin G (IgG) antibody titer, which indicates a secondary immune response. […] IFA and EIA tests can be used to confirm a diagnosis of Rickettsioses, but they do not identify the various rickettsial species. […] Polymerase chain reaction (PCR) amplification of rickettsial DNA of serum or skin biopsy specimens can be used for diagnosing, however test sensitivities are still to low to be considered a test of choice. […] No imaging studies are specifically indicated to aid in diagnosing typhus. Imaging studies are indicated only on a case-by-case basis to evaluate potential complications or as needed.
  • #11 Rickettsia typhi – Typhus Fever | Choose the Right Test
    https://arupconsult.com/content/rickettsia-typhi
    Serologic testing of immunoglobulin G (IgG) antibodies, often by IFA, is the standard method to confirm murine typhus. […] Diagnosis by serology requires both an acute specimen, collected within a week of symptom onset, and a convalescent specimen, collected 2-10 weeks after the acute sample. […] NAAT by polymerase chain reaction (PCR) can be used to confirm an R. typhi infection and is most sensitive when conducted within a week of symptom onset. […] The sensitivity of NAAT is affected by bacterial load (ie, the severity and stage of infection), so this testing should be performed before administering treatment, ideally within the first 5 days of febrile illness. […] IHC, which like IFA can be used to detect but not identify a rickettsial infection, is limited in availability to specialized laboratories, such as the CDC.
  • #11 Rickettsia typhi – Typhus Fever | Choose the Right Test
    https://arupconsult.com/content/rickettsia-typhi
    Rickettsia typhi is the fleaborne etiologic agent of murine typhus (also called endemic typhus), a leading global source of undifferentiated febrile illness. […] Infection by R. typhi is commonly diagnosed with two-step serologic testing, although other methods such as nucleic acid amplification testing (NAAT) and immunohistochemistry (IHC), when IHC is available, may also be used. […] Testing for R. typhi is indicated in patients who have symptoms consistent with infection (eg, a persistent fever accompanied by headache or a rash spreading from the trunk), particularly those who have traveled to a tropical or semitropical region and/or report exposure to common carriers (eg, rats) or their fleas. Symptoms usually occur within 7-14 days of exposure. […] Laboratory testing for R. typhi, a typhus group rickettsia, generally entails serology by immunofluorescence assay (IFA) but can also include NAAT and IHC testing.
  • #12 Information for Health Care Providers
    http://med.iiab.me/modules/en-cdc/www.cdc.gov/typhus/healthcare-providers/index.html
    The most rapid and specific diagnostic assays for scrub typhus rely on molecular methods like polymerase chain reaction (PCR), which can detect DNA in a whole blood, eschar swab, or tissue sample. […] Doxycycline is the treatment of choice for suspected scrub typhus in persons of all ages. […] Treatment should never be withheld pending diagnostic tests.
  • #13 Clinical Overview of Murine Typhus | Typhus Fevers | CDC
    https://www.cdc.gov/typhus/hcp/clinical-overview/clinical-overview-of-murine-typhus.html
    IHC can be used to detect infection with typhus group Rickettsia (including R. prowazekii and R. typhi) in formalin-fixed tissue samples. […] PCR of whole blood or tissue can distinguish between infection with R. typhi and R. prowazekii although the sensitivity of these assays varies considerably based on the sample type, timing of sample collection, and the severity of disease.
  • #14 Epidemic Typhus – Infections – Merck Manual Consumer Version
    https://www.merckmanuals.com/home/infections/rickettsial-and-related-infections/epidemic-typhus
    To diagnose the infection, doctors test a sample of the rash and sometimes do blood tests. […] The diagnosis of epidemic typhus is suggested by the symptoms, particularly if the person has body lice or has been in an area where there was an outbreak of typhus. […] To confirm the diagnosis, doctors may do an immunofluorescence assay, which uses a sample taken from the rash (biopsy). Or they may use the polymerase chain reaction (PCR) technique to enable them to detect the bacteria more rapidly. […] Doctors may do blood tests that detect antibodies to the bacteria. However, doing the test once is not enough. The test must be repeated 1 to 3 weeks later to check for an increase in the antibody level. Thus, antibody tests do not help doctors diagnose the infection immediately after someone becomes ill but can help confirm the diagnosis later.
  • #15 Typhus Fever: An Overlooked Diagnosis
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2761786/
    A case of typhus fever is presented. On admission, the clinical diagnosis was typhoid fever. Forty-eight hours after admission, the presence of subconjunctival haemorrhage, malena, and jaundice raised the possibility of a different aetiology, the two most likely differentials being dengue and typhus. Finally, a co-infection of typhoid and typhus was discovered. This uncommon clinical scenario should be taken into account in the management of patients with high fever on admission being treated as a case of typhoid fever. […] Epidemic and endemic typhus is sometimes misdiagnosed as typhoid fever in tropical countries. Similarly, co-infection of typhoid and typhus fever can be overlooked if not suspected clinically. High continued fever with variable associated symptoms, such as malaise, headache, and myalgia, are usually present in both typhoid and typhus fever. Jaundice and malena may also be present in some cases of both typhoid and typhus fever. However, signs such as subconjunctival haemorrhage should lead to a different aetiology of fever being considered, including typhus fever. Therefore, clinical suspicion is of paramount importance in the diagnosis of both typhoid and typhus fever. Confirmation of the diagnosis is important as the treatment is different but may not always be possible. In most cases of typhus, treatment is given based on clinical suspicion or a positive Weil-Felix test. In clinically-suspected cases of typhus fever, a rising titre of OXK, OX2, and OX19 antigens supports the diagnosis but confirmation of the diagnosis may be difficult.
  • #16 Typhus – Knowledge @ AMBOSS
    https://www.amboss.com/us/knowledge/typhus/
    Suspect the diagnosis in patients with clinical features and relevant exposure history. […] Confirmatory tests: for acute and recrudescent infections IFA test demonstrating a four-fold rise in rickettsial antibodies when comparing a sample taken during the first week of illness to a convalescent sample taken 24 weeks later. […] Initiate treatment early in all clinically suspected cases. […] First-line: doxycycline. […] Initiate treatment early in all clinically suspected cases. […] First-line: doxycycline. […] Suspect the diagnosis in patients with clinical features and relevant exposure history.
  • #17 Typhus: Causes, Symptoms, and Diagnosis
    https://www.healthline.com/health/typhus
    Typhus outbreaks usually only occur in developing countries or in regions of poverty, poor sanitation, and close human contact. […] Its important to see your doctor if you suspect that you may have typhus. […] Diagnosis is difficult because symptoms are common to other infectious diseases, including: dengue, also known as breakbone fever, malaria, an infectious disease spread by mosquitos, brucellosis, an infectious disease caused by Brucella bacterial species. […] Diagnostic tests for the presence of typhus include: skin biopsy: a sample of the skin from your rash will be tested in a lab, Western blot: a test to identify the presence of typhus, immunofluorescence test: uses fluorescent dyes to detect typhus antigen in samples of serum taken from the bloodstream, other blood tests: results can indicate the presence of infection. […] If you suspect that you have typhus, your doctor will ask about your symptoms and your medical history.
  • #18 Murine Typhus | Public Health and Medical Entomology | Purdue | Biology | Entomology | Insects | Ticks | Diseases | Monitoring | Control | Hot Topics | Agriculture | Extension
    https://extension.entm.purdue.edu/publichealth/diseases/flea/typhus.html
    Difficult because initial symptoms are similar to several other diseases, including epidemic typhus fever. […] Serological tests are needed to confirm a diagnosis.
  • #19 Typhus: Symptoms, Causes, Diagnosis, Treatment, Prevention
    https://www.webmd.com/a-to-z-guides/what-is-typhus/?amp=1
    If your doctor thinks you have typhus, youll get a blood test to check for typhus bacteria, especially if youve traveled to an area where typhus is common. […] It can sometimes take weeks to get those blood test results. So the doctor may recommend you start antibiotic treatment right away to be safe.
  • #20 Murine (Endemic) Typhus – Infections – Merck Manual Consumer Version
    https://www.merckmanuals.com/home/infections/rickettsial-and-related-infections/murine-endemic-typhus
    Murine typhus is a rickettsial disease that is caused by Rickettsia typhi and Rickettsia felis and spread by rat fleas. […] To diagnose the infection, doctors test a sample of the rash and sometimes do blood tests. […] The diagnosis of murine typhus is suggested by symptoms. […] To confirm the diagnosis, doctors may do an immunofluorescence assay, which uses a sample taken from the rash (biopsy). Or they may use the polymerase chain reaction (PCR) technique to enable them to detect the bacteria more rapidly. […] Doctors may do blood tests that detect antibodies to the bacteria. However, doing the test only once is not enough. The test must be repeated 1 to 3 weeks later to check for an increase in the antibody level. Thus, antibody tests do not help doctors diagnose the infection immediately after someone becomes ill but can help confirm the diagnosis later.
  • #21 Endemic Typhus Fever (flea-borne) – Epidemiology
    https://www.vdh.virginia.gov/epidemiology/epidemiology-fact-sheets/endemic-typhus-fever-flea-borne/
    Endemic typhus fever is a disease caused by bacteria called Rickettsia typhi or Rickettsia felis. […] The diagnosis of endemic typhus fever is based on signs and symptoms of illness, as well as laboratory tests of skin or blood.
  • #22 Epidemic typhus – UpToDate
    https://www.uptodate.com/contents/epidemic-typhus
    Epidemic typhus is a potentially lethal, louse-borne, exanthematous disease caused by Rickettsia prowazekii. R. prowazekii is one of two members of the typhus group of Rickettsia known to cause human illness; the other member, Rickettsia typhi, causes murine typhus. […] The epidemiology, pathogenesis, clinical manifestations, diagnosis, and treatment of epidemic typhus will be discussed here. […] It has been estimated that epidemic typhus has caused more deaths than all the wars in history. […] Epidemic typhus is now a rare disease, but subsequent developments illustrate that an understanding of its epidemiology, clinical features, and treatment is still important to clinicians.
  • #23 Epidemic Typhus Fever (louse-borne) – Epidemiology
    https://www.vdh.virginia.gov/epidemiology/epidemiology-fact-sheets/epidemic-typhus-fever-louse-borne/
    Epidemic typhus fever is a disease caused by bacteria called Rickettsia prowazekii. […] The diagnosis of epidemic typhus fever is based on signs and symptoms of illness, as well as laboratory tests of skin or blood. […] Epidemic typhus fever is treated with antibiotics. Healthcare providers choose the antibiotic based on the patients symptoms and the results of laboratory tests. […] There is currently no commercially available vaccine for epidemic typhus fever.
  • #24 Diagnosis of Scrub Typhus
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2829893/
    Scrub typhus is transmitted by trombiculid mites and is endemic to East and Southeast Asia and Northern Australia. The clinical syndrome classically consists of a fever, rash, and eschar, but scrub typhus also commonly presents as an undifferentiated fever that requires laboratory confirmation of the diagnosis, usually by indirect fluorescent antibody (IFA) assay. […] Diagnosis, therefore, depends on clinical suspicion, prompting the clinician to request an appropriate laboratory investigation, and failure to diagnose the disease will likely result in treatment with ineffective -lactambased regimens. […] The mainstay in scrub-typhus diagnostics remains serology. The oldest test in current use is the WeilFelix OX-K agglutination reaction, which is inexpensive, easy to perform, and results are available overnight; however, it lacks specificity and sensitivity. The indirect fluorescent antibody (IFA) test is more sensitive, and results are available in a couple of hours; however, the test is more expensive and requires considerable training. IFA uses fluorescent anti-human antibody to detect specific antibody from patient serum bound to a smear of scrub-typhus antigen and is currently the reference standard.
  • #25 Scrub Typhus Diagnostics: The Present and the Future
    https://zoonoses-journal.org/index.php/2024/02/21/scrub-typhus-diagnostics-the-present-and-the-future/
    Scrub typhus, caused by Orientia tsutsugamushi, is a vector-borne, zoonotic disease commonly occurring in a geographic region known as the tsutsugamushi triangle. Scrub typhus causes acute undifferentiated febrile illness (AUFI) with non-specific clinical features and is difficult to diagnose when a highly characteristic but not pathognomonic eschar is absent. Because the eschar is not always present, laboratory tests are required for diagnosis. Serological assays have been the mainstay of laboratory diagnosis of scrub typhus to date. Here, we present the major clinical features and clinical algorithms suggestive of this disease, to aid in better selection of diagnostic methods. The advantages and disadvantages of various scrub typhus assays are also discussed. Furthermore, we describe diagnostics, including serological and molecular assays, that may be available in the near future.
  • #26 Diagnosis of Scrub Typhus
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2829893/
    All currently available serological tests for scrub typhus have limitations in which clinicians need to be aware, despite their widespread use. Although agreement exists that a 4-fold increase in antibody titer between two consecutive samples is diagnostic, such a diagnosis is retrospective and cannot guide initial treatment. Diagnosis based on a single acute-serum sample requires using a cut-off antibody titer. Cut offs ranging from 1:10 to 1:400 are quoted, often with little corroborating evidence and without establishing titers in the healthy local population (necessary to distinguish background immunity from acute infection); that cut off is then used for all patients, irrespective of whether or not they come from a scrub-typhusendemic environment. […] Most frequently, IFA uses antigen from just three serotypes: Karp, Kato, and Gilliam. Yet, enormous antigenic variation has been found everywhere where it has been sought. The Infectious Disease Surveillance Center in Japan, therefore, recommends a two-pronged approach to diagnosis. First, local strains are included in the IFA for each prefecture; second, PCR of the blood clot is performed on all specimens, although buffy coat might be preferable. This recommendation is not widely implemented outside of Japan.
  • #27 Scrub Typhus Diagnostics: The Present and the Future – ScienceOpen
    https://www.scienceopen.com/hosted-document?doi=10.15212/ZOONOSES-2023-0028
    In the present review, current advances and practice in the diagnosis of scrub typhus are described. We also concisely discuss future diagnostic assays and their limitations, and provide several feasible suggestions. […] Even in the presence of an eschar and the demonstration of a response to rickettsia specific therapy, scrub typhus diagnosis requires confirmation through laboratory testing. Traditionally, four methods have been used to confirm the etiological agent of an infectious disease or syndrome: isolation of organisms, antigen detection, nucleic acid amplification tests (NAATs), and antibody detection assays. […] The best performance of serological assays for scrub typhus occurs during the second week of illness. The sensitivity is lowest for the Weil Felix test, reaching a maximum of 50%. The specificity has also been reported to be low, although we have consistently observed a specificity above 90%. A diagnosis of scrub typhus can be confirmed serologically by demonstrating a fourfold rise in titre; paired samples (acute and convalescent, taken at least 2 weeks apart) must be tested.
  • #27 Scrub Typhus Diagnostics: The Present and the Future – ScienceOpen
    https://www.scienceopen.com/hosted-document?doi=10.15212/ZOONOSES-2023-0028
    Scrub typhus, caused by Orientia tsutsugamushi, is a vector-borne, zoonotic disease commonly occurring in a geographic region known as the ‘tsutsugamushi triangle’. Scrub typhus causes acute undifferentiated febrile illness (AUFI) with non-specific clinical features and is difficult to diagnose when a highly characteristic but not pathognomonic eschar is absent. Because the eschar is not always present, laboratory tests are required for diagnosis. Serological assays have been the mainstay of laboratory diagnosis of scrub typhus to date. Here, we present the major clinical features and clinical algorithms suggestive of this disease, to aid in better selection of diagnostic methods. The advantages and disadvantages of various scrub typhus assays are also discussed. Furthermore, we describe diagnostics, including serological and molecular assays, that may be available in the near future.
  • #28 Diagnosis of Scrub Typhus
    https://pmc.ncbi.nlm.nih.gov/articles/PMC2829893/
    Isolating O. tsutsugamushi requires biosafety level-3 facilities and culture on cell monolayers; median time to positivity is 27 days. Current methods of isolation are, therefore, not appropriate for the routine diagnosis of scrub typhus. There is an urgent need for alternative diagnostic methods; however, evaluation is hampered, because the current gold standard (IFA) is imperfect. […] Clinicians will remain dependent on serological methods until these issues are resolved, but work can be done to optimize their performance. Cut offs must be validated locally, and previously undiscovered serotypes must be assiduously searched for by examining rodents and chiggers, not merely patient isolates. We propose that new diagnostic assays not be validated against IFA alone but instead, be compared against a panel of both serological and antigen-detection assays (e.g., IFA with 47-kDA and/or 56-kDa PCR).
  • #29 Performance of molecular and serologic tests for the diagnosis of scrub typhus | PLOS Neglected Tropical Diseases
    https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0008747
    Diagnosis of scrub typhus, caused by the bacterium Orientia tsutsugamushi, is challenging because of the overlap of its non-specific symptoms with other infections coupled with the lack of sufficient data on the performance of diagnostic tests. […] Early diagnosis of scrub typhus is crucial to improve outcomes and this study evaluates the diagnostic performance of various tests. […] The present study aims at assessing the accuracy of various rapid diagnostic tests, serologic tests, and nucleic acid amplification methods on well-characterized patient samples. […] The sensitivity and specificity of IFA were found to be 95% and 74% respectively. […] In conclusion, ELISA and RDT detecting Orientia tsutsugamushi specific IgM antibodies have excellent sensitivity and specificity while the accuracy of IFA is suboptimal for the diagnosis of scrub typhus.
  • #30 Diagnostic evaluation of IgM ELISA and IgM Immunofluorescence assay for the diagnosis of Acute Scrub Typhus in central Nepal | BMC Infectious Diseases | Full Text
    https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-4861-y
    The overall sensitivity and specificity of the IgM ELISA was 84.0% (95% CI: 79.7387.68%) and 94.82% (CI: 93.4395.99%) respectively in our study. […] InBios IgM ELISA is a sensitive and specific test and could be substitute for the IgM IFA in resource limited countries like Nepal. ELISA is comparatively cheaper and easier test with high throughput of the specimens. […] Indirect immunofluorescence assay (IFA) is considered to be the gold standard test for the diagnosis of scrub typhus, in which the patients serum containing the antibodies to Orientia tsutsugamushi are mixed to antigen on a slide, then detected using a fluorescently labeled anti-human antibody. […] Although IFA is loosely considered the gold standard diagnostic test, it is an imperfect reference test, particularly when using only acute samples for diagnosis.
  • #31 Scrub typhus point-of-care testing: A systematic review and meta-analysis | PLOS Neglected Tropical Diseases
    https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006330
    Diagnosing scrub typhus clinically is difficult, hence laboratory tests play a very important role in diagnosis. […] Accurate point-of-care testing (POCT) for scrub typhus diagnosis would be invaluable for patient diagnosis and management. […] The quality of the studies was assessed with the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2). […] Meta-analysis showed the pooled sensitivity and specificity of commercially available immunochromatographic tests (ICTs) were 66.0% (95% CI 0.370.86) and 92.0% (95% CI 0.830.97), respectively. […] Overall, the commercially available scrub typhus ICTs demonstrated better performance when ruling in the diagnosis. […] There is a need for standardised methods and reporting of diagnostic accuracy to decrease between-study heterogeneity and increase comparability among study results, as well as development of an affordable and accurate antigen-based POCT to tackle the inherent weaknesses associated with serological testing.
  • #32 Orientia tsutsugamushi (Scrub Typhus) | Public Health Ontario
    https://www.publichealthontario.ca/en/Laboratory-Services/Test-Information-Index/Orientia-Tsutsugamushi
    Testing is indicated for individuals with a history of exposure to mites in endemic areas and clinical presentation compatible with suspected scrub typhus. […] For serology, collecting both an acute serum (collected early after the onset of symptoms) and a convalescent serum (collected 2-3 weeks later) may be required for laboratory confirmation of infection. […] Orientia tsutsugamushi serology is performed at NML using the commercial InBios Scrub Typhus Detect IgM and IgG assays. This duplex assay provides semi-quantitative detection of IgM and IgG antibodies to an Orientia tsutsugamushi derived recombinant antigen. […] Single acute serology sensitivity is 60% when collected within the first week of illness. IgM may become detectable 5 to 10 days following symptom onset, while IgG titres may take weeks to become detectable. Overall, IgM and IgG sensitivity is estimated at 70-100% and 58-96%, respectively, while IgM and IgG specificity is estimated at 87-100% and 92-98%, respectively.
  • #32 Orientia tsutsugamushi (Scrub Typhus) | Public Health Ontario
    https://www.publichealthontario.ca/en/Laboratory-Services/Test-Information-Index/Orientia-Tsutsugamushi
    Serology may be negative in the acute stage of illness. False positive IgM results may occur and should be confirmed by collecting a convalescent serology sample. A positive IgM and IgG result does not distinguish active versus remote infection unless paired sera are collected demonstrating seroconversion. The current PCR and serology assays may not detect other rare non-tsutsugamushi Orientia species (e.g. Candidatus Orientia cholensis). […] A negative result does not exclude the diagnosis of rickettsial disease.
  • #33 Scrub Typhus Workup: Approach Considerations
    https://emedicine.medscape.com/article/971797-workup
    Routine laboratory studies in patients with scrub typhus reveal early lymphopenia with late lymphocytosis. A decrease in the CD4:CD8 lymphocyte ratio may also be noted. Thrombocytopenia is also seen. […] Elevated transaminase levels may be present in 75-95% of patients. Hypoalbuminemia occurs in about 50% of cases, whereas hyperbilirubinemia is rare. These findings may be especially prevalent in children. […] Laboratory studies of choice are serologic tests for antibodies. The main confirmatory tests are the indirect immunoperoxidase test and the immunofluorescent assay. […] An infection is confirmed by a 4-fold increase in antibody titers between acute and convalescent serum specimens. A single high titer with classic clinical features is considered a probable case. Serology for all suspected subtypes should be requested.
  • #34 Scrub Typhus Workup: Approach Considerations
    https://emedicine.medscape.com/article/971797-workup
    The indirect fluorescent antibody test is sensitive and provides results in a couple of hours. […] A study of 2 rapid immunochromatographic tests for detection of IgM and IgG against O tsutsugamushi determined that both assays were more sensitive and specific than the standard immune immunofluorescence assay for the early diagnosis of scrub typhus. […] O tsutsugamushi has been identified by means of the polymerase chain reaction (PCR) technique in clinical specimens. […] Performing nested PCR on the eschar might be a rapid diagnostic test for scrub typhus in the early, acute stage. […] The Weil-Felix OX-K strain agglutination reaction can be used to aid in diagnosis of scrub typhus. […] Chest radiography may reveal pneumonitis,
  • #35 Highly Sensitive Molecular Diagnostic Platform for Scrub Typhus Diagnosis Using O. tsutsugamushi Enrichment and Nucleic Acid Extraction
    https://www.mdpi.com/2079-6374/14/10/493
    Highly Sensitive Molecular Diagnostic Platform for Scrub Typhus Diagnosis Using O. tsutsugamushi Enrichment and Nucleic Acid Extraction […] Scrub typhus is caused by the Gram-negative obligate intracellular bacterium Orientia tsutsugamushi, and this tick-borne disease is difficult to distinguish from other acute febrile illnesses as it typically presents with symptoms such as rash, crusting at the bite site, headache, myalgia, lymphadenopathy, and elevated liver transaminases. It can often be diagnosed clinically, but not all patients present with characteristic symptoms, so serological diagnosis and molecular techniques may be required. However, existing diagnostic tests often have low sensitivity and specificity, making early detection difficult. This study presents a nucleic acid extraction method using large volumes of plasma and buffy coat to increase sensitivity, as well as an improved detection method using two target genes.
  • #36 :: JKMS :: Journal of Korean Medical Science
    https://jkms.org/DOIx.php?id=10.3346/jkms.2016.31.8.1190
    Diagnosis of scrub typhus is challenging due to its more than twenty serotypes and the similar clinical symptoms with other acute febrile illnesses including leptospirosis, murine typhus and hemorrhagic fever with renal syndrome. […] Accuracy and rapidity of a diagnostic test to Orientia tsutsugamushi is an important step to diagnose this disease. […] The sensitivity at the base of each IgM and IgG indirect immunofluorescent assay (IFA) in Korean patients was 98.6% and 97.1%, and the specificity was 98.2% and 97.7% respectively. […] ImmuneMed RDT shows superior sensitivity (98.6% and 97.1%) compared with SD Bioline RDT (84.4% at IgM and 83.3% at IgG) in Korea. […] The retrospective diagnosis of ImmuneMed RDT exhibits 94.0% identity with enzyme-linked Immunosorbent assay (ELISA) using South India patient serum samples.
  • #37 :: JKMS :: Journal of Korean Medical Science
    https://jkms.org/DOIx.php?id=10.3346/jkms.2016.31.8.1190
    The sensitivity and specificity of ImmuneMed RDT was 98.6% and 97.6%, but those of SD bioline RDT was 84.4% and 96.3% respectively. […] This result indicates that the ImmuneMed RDT shows excellent performance of sensitivity and specificity to diagnose scrub typhus compared with SD Biolines. […] This means that the selected antigens from five different serotypes and other technical improvement represent to similar or better performance with InBios tsutsugamushi ELISA. […] This indicates that the ImmuneMed RDT can replace ELISA test to diagnose scrub typhus as an easy and time saving diagnostic tool with high sensitivity and specificity.
  • #38 Scrub typhus point-of-care testing: A systematic review and meta-analysis | PLOS Neglected Tropical Diseases
    https://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0006330
    Therefore, there is clearly a need for affordable point-of-care testing (POCT) for scrub typhus diagnosis in endemic settings with resource constraints. […] The pooled sensitivity and specificity were 66.0% (95% CI 0.370.86) and 92.0% (95% CI 0.830.97), respectively. […] The meta-analysis showed moderately low pooled sensitivity and good specificity of the current commercially available scrub typhus POCT.
  • #39 Diagnosis of severe scrub typhus infection by next-generation sequencing:a case report | BMC Infectious Diseases | Full Text
    https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-04991-y
    Scrub typhus is an acute febrile illness, which was caused by Orientia tsutsugamushi and transmitted through the bite of chiggers. The diagnosis of scrub typhus could be missed diagnosis due to the absence of the pathognomonic eschar. […] Next-generation sequencing was a new diagnostic technology and could identify scrub typhus in accurately and fast without the pathognomonic eschar. […] The diagnosis of scrub typhus is difficult due to the absence of the pathognomonic eschar, which is the characteristic clinical manifestations and varies widely. […] Serology, biopsy, culture, and polymerase chain reaction were routine diagnostic methods and had many defects in the diagnosis. […] Polymerase chain reaction testing is only used as confirmatory test, but not as a screening test, because of multiple pathogenic bacterium in the clinic.
  • #40 Diagnosis of severe scrub typhus infection by next-generation sequencing:a case report | BMC Infectious Diseases | Full Text
    https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-020-04991-y
    Next-generation sequencing (NGS) technologies have been used in the diagnosis of other pathogens. […] However, the use of NGS has not been reported in the case of Scrub Typhus. […] In the 6th day after hospitalization, Orientia tsutsugamushi was determined to be the causative pathogen by NGS. […] NGS was a new diagnostic technology which could identify Scrub typhus in accurately and fast and would be a promising critical tool to find the aetiology of multiple organs failure or septic shock.
  • #41 GroEL Chaperonin-Based Assay for Early Diagnosis of Scrub Typhus
    https://www.mdpi.com/2075-4418/12/1/136
    The ICT AgTK for detecting the GroEL of O. tsutsugamushi in the frozen serum samples showed 85% diagnostic sensitivity, 100% diagnostic specificity and 92.5% accuracy, when compared with the clinical diagnosis and standard IFA. […] The ICT AgTK is easy to perform and has a rapid turn-around time. It should be used for on-site and early scrub typhus diagnosis, especially in resource-limited healthcare settings, by using the freshly collected samples, either serum, or plasma, or buffy coat.